Hyderabad: Natco Pharma has announced that K.M.V. Narayana Rao has been appointed as Vice President – ARD at NATCO Research Centre, effective June 12, 2024, through a recent BSE filing.
With over 28 years of expertise in analytical R&D in APls and NCEs, K.M.V. Narayana Rao has been a key contributor to primary registration documents in the GxP environment, including CMC, IND, ANDA, CEP, and DMF. Before that, in 2015, he was employed by M/s. Aragen Life Sciences Private Limited (previously GVKBIO) in Hyderabad, India, as Associate Vice President (Head Analytical). He graduated from Andhra University in Visakhapatnam, India, with a Ph.D. in analytical chemistry and an M.Sc. in physical chemistry.
In 1981, Natco Pharma Limited was founded in Hyderabad with an INR 3.3 million initial investment. Having started out as a small business with just 20 workers, Natco now has eight manufacturing facilities with state-of-the-art research labs, the ability to develop new drugs, and other features throughout India.
